(Q44527924)

3 December 2017

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis (English)

1 reference

3 December 2017

2

Raihanatou Diallo

0 references

Christopher Poremba

5

object named as

Christopher Poremba

1 reference

3 December 2017

Pia Wülfing

1

1 reference

3 December 2017

Raihanatou Diallo

2

1 reference

3 December 2017

Christine Müller

3

1 reference

3 December 2017

Christian Wülfing

4

1 reference

3 December 2017

Achim Heinecke

6

1 reference

3 December 2017

Achim Rody

7

1 reference

3 December 2017

Robert R Greb

8

1 reference

3 December 2017

Werner Böcker

9

1 reference

3 December 2017

Ludwig Kiesel

10

1 reference

3 December 2017

15 July 2003

1 reference

Journal of Cancer Research and Clinical Oncology

3 December 2017

1 reference

3 December 2017

129

1 reference

3 December 2017

375-382

1 reference

3 December 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-003-0459-1

3 December 2017

0 references

cites work

Human cyclooxygenase-2 cDNA

1 reference

12 December 2020

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

12 December 2020

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

1 reference

12 December 2020

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

12 December 2020

Aspirin use and chronic diseases: a cohort study of the elderly

1 reference

12 December 2020

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

1 reference

12 December 2020

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

1 reference

12 December 2020

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

1 reference

12 December 2020

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

1 reference

12 December 2020

The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer.

1 reference

12 December 2020

Carcinogen substrate specificity of human COX-1 and COX-2.

1 reference

12 December 2020

Telomerase activity in human proliferative breast lesions

1 reference

12 December 2020

Cyclooxygenase-2 gene expression is upregulated in transformed mammary epithelial cells

1 reference

12 December 2020

Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer

1 reference

12 December 2020

Breast cancer and NSAID use: a meta-analysis

1 reference

12 December 2020

Prostaglandins and breast cancer

1 reference

12 December 2020

Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer

1 reference

12 December 2020

Expression of cyclooxygenase-2 in prostate carcinoma.

1 reference

12 December 2020

Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract

1 reference

12 December 2020

Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor

1 reference

12 December 2020

Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.

1 reference

12 December 2020

Prospective study of regular aspirin use and the risk of breast cancer

1 reference

12 December 2020

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

12 December 2020

Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

1 reference

12 December 2020

Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.

1 reference

12 December 2020

Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor

1 reference

12 December 2020

Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model

1 reference

12 December 2020

Expression of cyclooxygenase-2 in human lung carcinoma

1 reference

12 December 2020

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

1 reference

12 December 2020

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

12 December 2020

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

1 reference

12 December 2020

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

1 reference

12 December 2020

Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder

1 reference

12 December 2020

Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

1 reference

12 December 2020

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry

1 reference

12 December 2020

Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas

1 reference

12 December 2020

Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.

1 reference

12 December 2020

Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.

1 reference

12 December 2020

10.1007/S00432-003-0459-1

Identifiers

DOI

1 reference

3 December 2017

1 reference